Overall, the results above indicated that activation of ERK1/2 and AMPKα involved in the β-elemene-reduced DNMT1 protein and that expression of DNMT1 was required in the β-elemene-inhibited lung cancer cell growth. This evidence concerns the gene DNMT1 and lung carcinoma.